Literature DB >> 7954442

Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM).

L A Cannon-Albright1, L J Meyer, D E Goldgar, C M Lewis, W P McWhorter, M Jost, D Harrison, D E Anderson, J J Zone, M H Skolnick.   

Abstract

A susceptibility locus for familial melanoma has been localized to the short arm of chromosome 9. Penetrance of melanoma was estimated by calculating the Kaplan-Meier function and fitting a log normal hazard function in 124 gene carriers in three 9p-linked kindreds. The penetrance of the gene for melanoma was estimated to be 53% by age 80. Additionally, nevus counts, skin type, and sun exposure histories were gathered for 119 individuals in two kindreds. Gene carriers were found to have higher nevus counts and nevus densities than non-gene carriers. Among gene carriers, individuals with melanoma were found to have more sun exposure within each skin type than gene carriers without melanoma. These analyses suggest that the 9p melanoma susceptibility is related to total number of nevi and that it interacts with other genetic and environmental factors to produce melanoma.

Entities:  

Mesh:

Year:  1994        PMID: 7954442

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Novel targeted therapies for the treatment of metastatic melanoma.

Authors:  Ragini Kudchadkar
Journal:  Ochsner J       Date:  2010

2.  Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi.

Authors:  A M Goldstein; L R Goldin; N C Dracopoli; W H Clark; M A Tucker
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

Review 3.  Barriers to risk-understanding and risk-reduction behaviors among individuals with a family history of melanoma.

Authors:  Laura Fitzpatrick; Jennifer L Hay
Journal:  Melanoma Manag       Date:  2014-12-04

4.  Melanoma: Molecular Pathogenesis and Therapeutic Management.

Authors:  Yuxin Liu; M Saeed Sheikh
Journal:  Mol Cell Pharmacol       Date:  2014

5.  Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families.

Authors:  Nicholas J Taylor; Nandita Mitra; Alisa M Goldstein; Margaret A Tucker; Marie-Françoise Avril; Esther Azizi; Wilma Bergman; D Timothy Bishop; Brigitte Bressac-de Paillerets; William Bruno; Donato Calista; Lisa A Cannon-Albright; Francisco Cuellar; Anne E Cust; Florence Demenais; David E Elder; Anne-Marie Gerdes; Paola Ghiorzo; Thais C Grazziotin; Johan Hansson; Mark Harland; Nicholas K Hayward; Marko Hocevar; Veronica Höiom; Christian Ingvar; Maria Teresa Landi; Gilles Landman; Alejandra Larre-Borges; Sancy A Leachman; Graham J Mann; Eduardo Nagore; Håkan Olsson; Jane M Palmer; Barbara Perić; Dace Pjanova; Antonia Pritchard; Susana Puig; Nienke van der Stoep; Karin A W Wadt; Linda Whitaker; Xiaohong R Yang; Julia A Newton Bishop; Nelleke A Gruis; Peter A Kanetsky
Journal:  J Invest Dermatol       Date:  2017-08-19       Impact factor: 8.551

6.  Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.

Authors:  M G FitzGerald; D P Harkin; S Silva-Arrieta; D J MacDonald; L C Lucchina; H Unsal; E O'Neill; J Koh; D M Finkelstein; K J Isselbacher; A J Sober; D A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

7.  Better the devil you know? High-risk individuals' anticipated psychological responses to genetic testing for melanoma susceptibility.

Authors:  Nadine A Kasparian; Bettina Meiser; Phyllis N Butow; R F Soames Job; Graham J Mann
Journal:  J Genet Couns       Date:  2006-12       Impact factor: 2.537

8.  Skin cancer screening behaviours among individuals with a strong family history of malignant melanoma.

Authors:  N A Kasparian; J K McLoone; B Meiser; P N Butow; J M Simpson; G J Mann
Journal:  Br J Cancer       Date:  2010-10-26       Impact factor: 7.640

9.  Down-regulation of a novel actin-binding molecule, skeletrophin, in malignant melanoma.

Authors:  Tamotsu Takeuchi; Henry H Q Heng; Christine J Ye; Sheng-Ben Liang; Jun Iwata; Hiroshi Sonobe; Yuji Ohtsuki
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 10.  Malignant melanoma in the 21st century: the emerging molecular landscape.

Authors:  Aleksandar Sekulic; Paul Haluska; Arlo J Miller; Josep Genebriera De Lamo; Samuel Ejadi; Jose S Pulido; Diva R Salomao; Erik C Thorland; Richard G Vile; David L Swanson; Barbara A Pockaj; Susan D Laman; Mark R Pittelkow; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2008-07       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.